UCP Knowledge NetworkApplied knowledge for action
Rows of sealed pallets in a storage facility illustrate the logistics behind managing and deploying medical countermeasures across the EU

Turning strategy into capacity: the EU’s plan for medical stockpiles

By Knowledge Network – Staff memberPublished on

In a world facing unpredictable challenges, from climate change to shifting geopolitical landscapes, the importance of being prepared has never been greater.

The European Commission prioritises public health preparedness in the EU Stockpiling Strategy, which aims to elevate crisis readiness and strengthen health security in Europe by ensuring essential medical supplies are available in case of a new health emergency. 

Published alongside the Medical Countermeasures Strategy, the EU strategic plan for stockpiling medical countermeasures provides a roadmap for EU-level stockpiling of crucial resources such as vaccines and therapeutics, to better protect citizens from future health crises. 

Key objectives and framework 

The plan seeks to enhance preparedness and ensure a rapid response during health emergencies. Learning from past crises, particularly COVID-19, the plan builds on needs assessment, coordinated procurement and sustainable. By emphasising resilience, the plan complements national reserves and strengthens Member State solidarity. Established in 2021, the Health Emergency Preparedness and Response Authority (HERA) plays a key role, with its mandate to ensure access to medical countermeasures. 
 

A technician handles a blood sample in a laboratory setting

The plan outlines strategic actions in procurement, management, deployment and sustainability: 

  1. identification of needs – regularly update a compendium of priority medical countermeasures to align with evolving threats;
  2. procurement – use flexible methods to efficiently acquire these countermeasures, keeping stocks current;
  3. management and governance – ensure quality control and regulatory compliance, including a pilot on ultra-long storage for active pharmaceutical ingredients (APIs) and rapid manufacturing, addressing issues such as interoperability with national reserves;
  4. deployment and logistics – set clear processes for cross-border operations and explore innovations, such as response kits;
  5. sustainability and collaboration – pilot shelf-life extensions, secure predictable funding and align with global partners. 

Challenges and considerations 

Bringing the plan to life involves several challenges. Regulatory and quality requirements, while essential, can slow access to vital supplies. Logistics and coordination remain critical, as moving countermeasures across borders demands seamless collaboration and rapid communication. Without this, delays undermine effectiveness. Funding uncertainty adds complexity, as there is currently no dedicated EU budget for replenishment after deployment. 

Conclusion and next steps 

The plan aims to ensure critical medical supplies are available when needed. HERA, in close cooperation with the Directorate-General for European Civil Protection and Humanitarian Aid Operations (DG ECHO), The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC), has already launched initiatives, such as the shelf-life extension pilot. Implementing this strategy requires sustained political support, secured funding, and expertise to connect policy with real-world response. For more information, visit the European Commission’s Health Emergency Preparedness and Response Authority (HERA) website.